Saturday 17 October 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024. In the quarter to June 2026, revenue grew 21.6%, EPS grew 112.0%, free cash flow fell 153.7% and total debt rose 70.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.
64.72
6.41
−9.01%
Follow TEM
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
2.60 | (1.69) | — | — |
P/S ratio |
8.09 | 5.84 | 4.54 | 4.54 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(1.60) | (9.85) | (9.79) | (6.63) |
P/Operating CF |
(279.72) | (103.08) | (25.18) | (25.18) |
Beneish M-Score |
(1.25) | (4.73) | (2.35) | — |
P/B ratio |
20.94 | 71.82 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
8.47 | 5.82 | 5.17 | 5.17 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(49.41) | (21.33) | (11.64) | (11.64) |
EV/FCF |
(43.92) | (19.10) | (10.23) | (10.23) |
Quick Ratio |
2.86 | 2.07 | 1.26 | 2.25 |
Current Ratio |
3.13 | 2.29 | 1.51 | 2.52 |
Net Debt/EBITDA |
(3.32) | 0.02 | (1.62) | (0.38) |
Debt/Assets |
54.49% | 47.02% | 79.72% | 61.70% |
Debt/Equity |
2.52 | 7.73 | (0.33) | (0.34) |
Asset Turnover |
0.79 | 0.93 | 0.89 | 0.00 |
Operating CF/Net income |
0.89 | 0.25 | 0.81 | 0.50 |
Capex/Depreciation |
(0.26) | (0.50) | (0.86) | (0.52) |
Interest Coverage |
(3.60) | (12.88) | (4.18) | (12.12) |
| (89.48%) | 112.58% | 21.18% | 0.00% | |
| (15.31%) | (100.17%) | (44.50%) | 0.00% | |
ROIC |
(16.20%) | (992.66%) | 0.00% | 0.00% |
Return on Tangible Assets |
(27.72%) | (171.73%) | (148.26%) | (108.24%) |
Average Days of Receivables |
89.30 | 81.50 | 64.83 | 100.94 |
Research and Development Expense of Revenue |
25.09% | 45.69% | 34.88% | 50.60% |
Selling, General and Administrative Expense of Revenue |
57.54% | 108.93% | 55.80% | 72.78% |
Intangible Assets out of Total Assets |
0.36 | 0.09 | 0.17 | 0.14 |
Share Based Compensation of Revenue |
9.81% | 77.03% | 0.00% | 0.00% |
Graham Net Nets |
(0.06) | (0.05) | (0.66) | (0.66) |
Graham Number |
0.00 | 0.00 | 40.76 | 0.00 |
Earnings Yield |
(2.39%) | (24.94%) | (8.80%) | (8.80%) |
Free Cash Flow Yield |
(2.38%) | (5.22%) | (11.12%) | (11.12%) |
Revenue per Share |
7.30 | 5.79 | 8.40 | 5.09 |
Operating CF per Share |
(1.25) | (1.58) | (3.39) | (2.67) |
Capex per Share |
(0.16) | (0.18) | (0.55) | (0.29) |
Free Cash Flow per Share |
(1.41) | (1.76) | (3.93) | (2.96) |
Cash per Share |
4.33 | 3.74 | 3.12 | 4.81 |
Shareholders Equity per Share |
2.82 | 0.47 | (21.83) | (17.91) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.82 | 0.47 | (21.83) | (17.91) |
Free Cash Flow |
(245.35) | (211.17) | (248.95) | (186.58) |
Working Capital |
794.79 | 376.53 | 117.70 | 264.39 |
Capital Expenditures |
(27.26) | (22.12) | (34.61) | (18.38) |
Net Current Asset Value |
(616.34) | (202.17) | (1,595.88) | (1,321.76) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.03 | 0.07 | 0.06 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
1.20 | 0.76 | 0.65 | 0.81 |
Cash ROIC |
(9.87%) | (22.46%) | 33.87% | 42.74% |
Accounts Receivable Turnover |
5.46 | 5.56 | 5.81 | 0.00 |
Accounts Payable Turnover |
6.98 | 5.77 | 4.89 | 0.00 |
Inventory Turnover |
10.52 | 9.29 | 9.61 | 0.00 |
Average Days of Payables |
63.15 | 62.89 | 80.86 | 88.12 |
Days of Inventory on Hand |
39.84 | 44.87 | 42.86 | 42.70 |
Average Receivables |
232.99 | 124.64 | 91.57 | — |
Average Payables |
67.90 | 54.11 | 50.20 | — |
Average Inventory |
45.06 | 33.62 | 25.56 | — |
Average Assets |
1,600.48 | 745.08 | 597.71 | — |
Average Common Equity |
273.83 | (662.91) | (1,255.59) | — |
Columns are period end dates